logo
Plus   Neg
Share
Email

Perrigo Recalls Albuterol Sulfate Inhalation Aerosols Due To Clogging Concerns

Perrigo Company plc. (PRGO) said Thursday that it has voluntarily recalled albuterol sulfate inhalation aerosols over concerns that some units may not dispense properly due to clogging.

Perrigo's generic albuterol sulfate inhalation aerosol was developed in partnership with and manufactured by Catalent Pharma Solutions.

The company has already halted production and distribution of the aerosols.

"Corrective action plans are underway and a definitive timeline for product reintroduction has not been determined at this time," the company said in a statement.

Perrigo expects to take a charge of about $18 million to $22 million in the third quarter relating to the recall. It has not recorded any sales of the product since late August 2020.

The company reaffirmed its fiscal year 2020 adjusted earnings per share guidance in a range of $3.95 to $4.15 due to continued strong consumer demand in the Consumer Self-Care Americas business and faster than projected recoveries in the Consumer Self-Care International and base Rx businesses that were negatively impacted by COVID-19 lock-downs. Analysts polled by Thomson Reuters expect the company to report earnings of $4.08 per share for fiscal year 2020. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT